RX 336M: RN given refers to (4aR-(4a alpha,6a beta,10aR*,11 alpha,12c alpha))-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 197073 |
| MeSH ID | M0048184 |
| Synonym |
|---|
| morphinan, 3,4-dimethyl-1,2,5,6-tetrahydrobenz(2,1,8,8a)4,5-epoxy-3-methoxy-n-methyl-6-oxo-7,8-dihydro- |
| brn 1175588 |
| (4ar-(4aalpha,6abeta,10ar*,11alpha,12calpha))-6,6a,9,10,11,12-hexahydro-3-methoxy-7,8,15-trimethyl-11,12c-(iminoethano)-12ch-benzo(1,10a)phenanthro(4,5-bcd)furan-5(4ah)-one |
| rx 336m |
| 6701-66-2 |
| 8-methoxy-3,4,14-trimethyl-1,2,4a,5,12,13,14,15-octahydro-11,15-methanobenzo[i]benzofuro[3,2-e]isoquinolin-6(6ah)-one |
| 8-methoxy-3,4,14-trimethyl-1,2,4a,5,12,13,14,15-octahydro-11,15-methano[1]benzofuro[3,2-e]benzo[i]isoquinolin-6(6ah)-one |
| DTXSID30985831 |
| 13-methoxy-5,6,19-trimethyl-11-oxa-19-azahexacyclo[10.9.1.01,10.02,7.02,18.016,22]docosa-5,12,14,16(22)-tetraen-9-one |
| AKOS040753872 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.37) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||